Loading...
Header Logo
Keywords
Last Name
KP Region

Katrina AB Goddard, PhD

TitleSenior Investigator
InstitutionKaiser Permanente Northwest
DepartmentCenter for Health Research - Northwest
ORCID ORCID Icon0000-0001-9535-8993 Additional info
vCardDownload vCard
    Other Positions
    TitleAssociate Director, Science Programs
    InstitutionKaiser Permanente Northwest
    DepartmentCenter for Health Research - Northwest

    TitleCenter for Health Research Distinguished Investigator
    InstitutionKaiser Permanente Northwest
    DepartmentCenter for Health Research - Northwest


    Collapse Overview 
    Collapse overview
    Katrina Goddard, PhD, is a genetic epidemiologist who focuses on public health genomics and the translation of genetic testing into practice. She joined the Kaiser Permanente Center for Health Research in 2007.

    Dr. Goddard is the principal investigator of a study funded by the National Human Genome Research Institute (NHGRI) that is exploring how to use whole-genome sequencing in everyday clinical practice. The study will test would-be parents for genetic mutations that could cause rare but serious diseases in their children. Couples who get usual care will be compared with couples who get tested with whole-genome sequencing.

    Dr. Goddard founded the NW Biobank, a repository of blood and tissue samples linked to health plan members’ comprehensive electronic medical records. The biobank enables researchers to connect people’s genetic information with their health care, such as vital signs, diagnoses, and treatments. This regional biobank was recently assimilated into a national initiative called the Kaiser Permanente Research Bank.

    Dr. Goddard directs the Knowledge Synthesis Team and is co-chair of the Actionability Work Group for NHGRI’s ClinGen Consortium. The team provides a detailed summary for each gene or phenotype topic that is used by the work group to produce a semi-quantitative metric score. Other recent research includes implementing screening for Lynch syndrome in a managed care setting and a large comparative effectiveness research project on genomic and personalized medicine for colon cancer (CERGEN).

    Prior to her appointment as a Senior Investigator, Dr. Goddard was on the faculty at Case Western Reserve University in the Division of Genetic & Molecular Epidemiology. She was involved in several large-scale gene discovery projects there and was associate director of the Human Genetic Analysis Resource, which produces the SAGE software package. She received her PhD in biostatistics from the University of Washington in 1999 and a BS in molecular biology from the University of Wisconsin-Madison.

    Collapse Research 
    Collapse research activities and funding
    R01HG001577     (GODDARD, KATRINA A)Aug 1, 1996 - Jul 31, 2005
    NIH/NHGRI
    Robust Linkage Methods for Human Pedigree Data
    Role: Principal Investigator

    RC2CA148471     (GODDARD, KATRINA A)Sep 29, 2009 - Aug 31, 2011
    NIH/NCI
    Comparative effectiveness in genomic &personalized medicine for colon cancer
    Role: Principal Investigator

    UC2CA148471     (GODDARD, KATRINA A)Sep 29, 2009 - Aug 31, 2012
    NIH/NCI
    Comparative effectiveness in genomic &personalized medicine for colon cancer
    Role: Principal Investigator

    U18GD000076     (WHITLOCK, EVELYN P)Sep 30, 2010 - Sep 29, 2013
    CDC/OGDP
    Knowledge Synthesis Center for Genomic Applications
    Role: Co-Principal Investigator

    R01CA140377     (GODDARD, KATRINA A)Sep 2, 2011 - Jul 31, 2016
    NIH/NCI
    Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
    Role: Principal Investigator

    UM1HG007292     (GODDARD, KATRINA A.)Jun 14, 2013 - May 31, 2017
    NIH/NHGRI
    Clinical Implementation of Carrier Testing using NGS
    Role: Principal Investigator

    U01HG007292     (GODDARD, KATRINA A.)Jun 14, 2013 - May 31, 2021
    NIH/NHGRI
    Exome sequencing in Diverse Populations in Colorado & Oregon
    Role: Principal Investigator

    U41HG009650     (BERG, JONATHAN S)Sep 12, 2017 - Jul 31, 2021
    NIH/NHGRI
    The Clinical Genome Resource - Expert Curation and EHR Integration
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld O, Lee K, Lindor NM, Martin CL, Milosavljevic A, Mittendorf KF, Muessig KR, O'Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Sobriera NLM, Weaver MA, Williams MS, Evans JP, Goddard KAB. Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. Hum Mutat. 2018 Nov; 39(11):1677-1685. PMID: 30311382.
      View in: PubMed
    2. Rope AF, Kauffman TL, Himes P, Amendola LM, Punj S, Akkari Y, Potter A, Davis JV, Schneider JL, Reiss JA, Gilmore MJ, McMullen CK, Nickerson DA, Richards CS, Jarvik GP, Wilfond BS, Goddard KAB. A case for expanding carrier testing to include actionable X-linked disorders. Clin Case Rep. 2018 Nov; 6(11):2092-2095. PMID: 30455898.
      View in: PubMed
    3. Clarke EV, Schneider JL, Lynch F, Kauffman TL, Leo MC, Rosales AG, Dickerson JF, Shuster E, Wilfond BS, Goddard KAB. Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. PLoS One. 2018; 13(7):e0200139. PMID: 30020962.
      View in: PubMed
    4. Schneider JL, Goddard KAB, Muessig KR, Davis JV, Rope AF, Hunter JE, Peterson SK, Acheson LS, Syngal S, Wiesner GL, Reiss JA. Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews. Hered Cancer Clin Pract. 2018; 16:11. PMID: 29760830.
      View in: PubMed
    5. Lynch FL, Himes P, Gilmore MJ, Morris EM, Schneider JL, Kauffman TL, Shuster E, Reiss JA, Dickerson JF, Leo MC, Davis JV, McMullen CK, Wilfond BS, Goddard KAB. Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing. J Genet Couns. 2018 Aug; 27(4):823-833. PMID: 29423569.
      View in: PubMed
    6. Kauffman TL, Irving SA, Leo MC, Gilmore MJ, Himes P, McMullen CK, Morris E, Schneider J, Wilfond BS, Goddard KAB. The NextGen Study: patient motivation for participation in genome sequencing for carrier status. Mol Genet Genomic Med. 2017 Sep; 5(5):508-515. PMID: 28944234.
      View in: PubMed
    7. Hunter JE, Arnold KA, Cook JE, Zepp J, Gilmore MJ, Rope AF, Davis JV, Bergen KM, Esterberg E, Muessig KR, Peterson SK, Syngal S, Acheson L, Wiesner G, Reiss J, Goddard KAB. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer. 2017 07; 16(3):377-387. PMID: 28176204.
      View in: PubMed
    8. Gilmore MJ, Schneider J, Davis JV, Kauffman TL, Leo MC, Bergen K, Reiss JA, Himes P, Morris E, Young C, McMullen C, Wilfond BS, Goddard KAB. Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing. J Genet Couns. 2017 Oct; 26(5):971-979. PMID: 28315134.
      View in: PubMed
    9. Himes P, Kauffman TL, Muessig KR, Amendola LM, Berg JS, Dorschner MO, Gilmore M, Nickerson DA, Reiss JA, Richards CS, Rope AF, Simpson DK, Wilfond BS, Jarvik GP, Goddard KAB. Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing. Genet Med. 2017 07; 19(7):803-808. PMID: 28079899.
      View in: PubMed
    10. Kauffman TL, Wilfond BS, Jarvik GP, Leo MC, Lynch FL, Reiss JA, Richards CS, McMullen C, Nickerson D, Dorschner MO, Goddard KA. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. Contemp Clin Trials. 2017 02; 53:100-105. PMID: 27940182.
      View in: PubMed
    11. Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K, Martin CL, Milko L, Muessig K, Niehaus AD, O'Daniel J, Piper MA, Ramos EM, Schully SD, Scott AF, Slavotinek A, Sobreira N, Strande N, Weaver M, Webber EM, Williams MS, Berg JS, Evans JP, Goddard KA. A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. Genet Med. 2016 12; 18(12):1258-1268. PMID: 27124788.
      View in: PubMed
    12. Leo MC, McMullen C, Wilfond BS, Lynch FL, Reiss JA, Gilmore MJ, Himes P, Kauffman TL, Davis JV, Jarvik GP, Berg JS, Harding C, Kennedy KA, Simpson DK, Quigley DI, Richards CS, Rope AF, Goddard KA. Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing. Am J Med Genet A. 2016 Mar; 170(3):574-82. PMID: 26792268; PMCID: PMC4824299 [Available on 03/01/17].
    13. Schneider JL, Goddard KA, Davis J, Wilfond B, Kauffman TL, Reiss JA, Gilmore M, Himes P, Lynch FL, Leo MC, McMullen C. "Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening. J Genet Couns. 2016 Feb; 25(1):135-45. PMID: 26093606; PMCID: PMC4726717.
    14. Hunter JE, Zepp JM, Gilmore MJ, Davis JV, Esterberg EJ, Muessig KR, Peterson SK, Syngal S, Acheson LS, Wiesner GL, Reiss JA, Goddard KA. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. Cancer. 2015 Sep 15; 121(18):3281-9. PMID: 26036338; PMCID: PMC4560979.
    15. Schneider JL, Davis J, Kauffman TL, Reiss JA, McGinley C, Arnold K, Zepp J, Gilmore M, Muessig KR, Syngal S, Acheson L, Wiesner GL, Peterson SK, Goddard KA. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. Genet Med. 2016 Feb; 18(2):152-61. PMID: 25880440; PMCID: PMC4608844.
    16. Webber EM, Kauffman TL, O'Connor E, Goddard KA. Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. BMC Cancer. 2015 Mar 21; 15:156. PMID: 25884995; PMCID: PMC4376504.
    17. Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. J Natl Cancer Inst. 2015 Apr; 107(4). PMID: 25688116; PMCID: PMC4342676.
    18. Henrikson NB, Webber EM, Goddard KA, Scrol A, Piper M, Williams MS, Zallen DT, Calonge N, Ganiats TG, Janssens AC, Zauber A, Lansdorp-Vogelaar I, van Ballegooijen M, Whitlock EP. Family history and the natural history of colorectal cancer: systematic review. Genet Med. 2015 Sep; 17(9):702-12. PMID: 25590981; PMCID: PMC4955831.
    19. Simpson CL, Goldenberg AJ, Culverhouse R, Daley D, Igo RP, Jarvik GP, Mandal DM, Mascalzoni D, Montgomery CG, Pierce B, Plaetke R, Shete S, Goddard KA, Stein CM. Practical barriers and ethical challenges in genetic data sharing. Int J Environ Res Public Health. 2014 Aug 15; 11(8):8383-98. PMID: 25153467; PMCID: PMC4143867.
    20. Feigelson HS, Goddard KA, Hollombe C, Tingle SR, Gillanders EM, Mechanic LE, Nelson SA. Approaches to integrating germline and tumor genomic data in cancer research. Carcinogenesis. 2014 Oct; 35(10):2157-63. PMID: 25115441; PMCID: PMC4178473.
    21. Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genet Med. 2015 Jan; 17(1):63-7. PMID: 24946156; PMCID: PMC4272332.
    22. Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KA. Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. PLoS One. 2014; 9(5):e94977. PMID: 24788807; PMCID: PMC4006772.
    23. Musser ED, Hawkey E, Kachan-Liu SS, Lees P, Roullet JB, Goddard K, Steiner RD, Nigg JT. Shared familial transmission of autism spectrum and attention-deficit/hyperactivity disorders. J Child Psychol Psychiatry. 2014 Jul; 55(7):819-27. PMID: 24444366; PMCID: PMC4211282.
    24. Thameem F, Igo RP, Freedman BI, Langefeld C, Hanson RL, Schelling JR, Elston RC, Duggirala R, Nicholas SB, Goddard KA, Divers J, Guo X, Ipp E, Kimmel PL, Meoni LA, Shah VO, Smith MW, Winkler CA, Zager PG, Knowler WC, Nelson RG, Pahl MV, Parekh RS, Kao WH, Rasooly RS, Adler SG, Abboud HE, Iyengar SK, Sedor JR. A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND). PLoS One. 2013; 8(12):e81888. PMID: 24358131; PMCID: PMC3866106.
    25. Harris JN, Liljestrand P, Alexander GL, Goddard KA, Kauffman T, Kolevska T, McCarty C, O'Neill S, Pawloski P, Rahm A, Williams A, Somkin CP. Oncologists' attitudes toward KRAS testing: a multisite study. Cancer Med. 2013 Dec; 2(6):881-8. PMID: 24403261; PMCID: PMC3892392.
    26. Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KA, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. J Natl Cancer Inst. 2013 Jul 03; 105(13):929-36. PMID: 23661804; PMCID: PMC3699435.
    27. Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med. 2013 Dec; 15(12):933-40. PMID: 23639899; PMCID: PMC3855589.
    28. Goddard KA, Whitlock EP, Berg JS, Williams MS, Webber EM, Webster JA, Lin JS, Schrader KA, Campos-Outcalt D, Offit K, Feigelson HS, Hollombe C. Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med. 2013 Sep; 15(9):721-8. PMID: 23558254; PMCID: PMC3927794.
    29. Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):508-16. PMID: 23462917.
      View in: PubMed
    30. Behl AS, Goddard KA, Flottemesch TJ, Veenstra D, Meenan RT, Lin JS, Maciosek MV. Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst. 2012 Dec 05; 104(23):1785-95. PMID: 23197490; PMCID: PMC3514165.
    31. Betsou F, Gunter E, Clements J, DeSouza Y, Goddard KA, Guadagni F, Yan W, Skubitz A, Somiari S, Yeadon T, Chuaqui R. Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. J Mol Diagn. 2013 Jan; 15(1):3-16. PMID: 23195791.
      View in: PubMed
    32. Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101. PMID: 23155138; PMCID: PMC3567775.
    33. Goddard KA, Bowles EJ, Feigelson HS, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA. Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care. 2012 Nov; 18(11):704-12. PMID: 23198713; PMCID: PMC4061608.
    34. Lin JS, Thompson M, Goddard KA, Piper MA, Heneghan C, Whitlock EP. Evaluating genomic tests from bench to bedside: a practical framework. BMC Med Inform Decis Mak. 2012 Oct 19; 12:117. PMID: 23078403; PMCID: PMC3538070.
    35. Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305. PMID: 22949432; PMCID: PMC3433392.
    36. Deverka PA, Schully SD, Ishibe N, Carlson JJ, Freedman A, Goddard KA, Khoury MJ, Ramsey SD. Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med. 2012 Jul; 14(7):656-62. PMID: 22481130; PMCID: PMC4437504.
    37. Goddard KA, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL. Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med. 2012 Jul; 14(7):633-42. PMID: 22516979; PMCID: PMC3632438.
    38. Feigelson HS, Goddard KA, Johnson MA, Funk KC, Rahm AK, Kauffman TL, Chitale DA, Le Marchand L, Richards CS. Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories. BMC Res Notes. 2012 Apr 25; 5:196. PMID: 22534075; PMCID: PMC3441241.
    39. Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):673-80. PMID: 22337532; PMCID: PMC3319397.
    40. Trail-Mahan T, Mao CL, Bawel-Brinkley K. Complementary and alternative medicine: nurses' attitudes and knowledge. Pain Manag Nurs. 2013 Dec; 14(4):277-286. PMID: 24315251.
      View in: PubMed
    41. Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L, Berthiaume Y, Cutler D, Cojocaru A, Collaco JM, Corey M, Dorfman R, Goddard K, Green D, Kent JW, Lange EM, Lee S, Li W, Luo J, Mayhew GM, Naughton KM, Pace RG, Paré P, Rommens JM, Sandford A, Stonebraker JR, Sun W, Taylor C, Vanscoy LL, Zou F, Blangero J, Zielenski J, O'Neal WK, Drumm ML, Durie PR, Knowles MR, Cutting GR. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet. 2011 Jun; 43(6):539-46. PMID: 21602797; PMCID: PMC3296486.
    42. Goddard KA, Weinmann S, Richert-Boe K, Chen C, Bulkley J, Wax C. HER2 evaluation and its impact on breast cancer treatment decisions. Public Health Genomics. 2012; 15(1):1-10. PMID: 21540562; PMCID: PMC3225235.
    43. Rolnick SJ, Rahm AK, Jackson JM, Nekhlyudov L, Goddard KA, Field T, McCarty C, Nakasato C, Roblin D, Anderson CP, Valdez R. Barriers in identification and referral to genetic counseling for familial cancer risk: the perspective of genetic service providers. J Genet Couns. 2011 Jun; 20(3):314-22. PMID: 21503824.
      View in: PubMed
    44. Igo RP, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, Hanson RL, Duggirala R, Divers J, Abboud H, Adler SG, Arar NH, Horvath A, Elston RC, Bowden DW, Guo X, Ipp E, Kao WH, Kimmel PL, Knowler WC, Meoni LA, Molineros J, Nelson RG, Pahl MV, Parekh RS, Rasooly RS, Schelling JR, Shah VO, Smith MW, Winkler CA, Zager PG, Sedor JR, Freedman BI. Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol. 2011; 33(5):381-9. PMID: 21454968; PMCID: PMC3078269.
    45. Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med. 2011 Jan; 40(1):61-6. PMID: 21146769.
      View in: PubMed
    46. Silva LK, Blanton RE, Parrado AR, Melo PS, Morato VG, Reis EA, Dias JP, Castro JM, Vasconcelos PF, Goddard KA, Barreto ML, Reis MG, Teixeira MG. Dengue hemorrhagic fever is associated with polymorphisms in JAK1. Eur J Hum Genet. 2010 Nov; 18(11):1221-7. PMID: 20588308; PMCID: PMC2950898.
    47. Wellek S, Goddard KA, Ziegler A. A confidence-limit-based approach to the assessment of Hardy-Weinberg equilibrium. Biom J. 2010 Apr; 52(2):253-70. PMID: 20394081.
      View in: PubMed
    48. Darrah R, McKone E, O'Connor C, Rodgers C, Genatossio A, McNamara S, Gibson R, Stuart Elborn J, Ennis M, Gallagher CG, Kalsheker N, Aitken M, Wiese D, Dunn J, Smith P, Pace R, Londono D, Goddard KA, Knowles MR, Drumm ML. EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity. Physiol Genomics. 2010 Mar 03; 41(1):71-7. PMID: 20028935; PMCID: PMC2841492.
    49. Goddard KA, Ziegler A, Wellek S. Adapting the logical basis of tests for Hardy-Weinberg Equilibrium to the real needs of association studies in human and medical genetics. Genet Epidemiol. 2009 Nov; 33(7):569-80. PMID: 19235187.
      View in: PubMed
    50. Malhotra A, Igo RP, Thameem F, Kao WH, Abboud HE, Adler SG, Arar NH, Bowden DW, Duggirala R, Freedman BI, Goddard KA, Ipp E, Iyengar SK, Kimmel PL, Knowler WC, Kohn O, Leehey D, Meoni LA, Nelson RG, Nicholas SB, Parekh RS, Rich SS, Chen YD, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Taylor KD, Thornley-Brown D, Zager PG, Horvath A, Hanson RL. Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group. Diabetes Metab Res Rev. 2009 Nov; 25(8):740-7. PMID: 19795399; PMCID: PMC2783577.
    51. Goddard KA, Smith KS, Chen C, McMullen C, Johnson C. Biobank Recruitment: Motivations for Nonparticipation. Biopreserv Biobank. 2009 Jun; 7(2):119-121. PMID: 22087353.
      View in: PubMed
    52. Igo RP, Li J, Goddard KA. Association mapping by generalized linear regression with density-based haplotype clustering. Genet Epidemiol. 2009 Jan; 33(1):16-26. PMID: 18561202; PMCID: PMC2952426.
    53. Goddard KA, Duquette D, Zlot A, Johnson J, Annis-Emeott A, Lee PW, Bland MP, Edwards KL, Oehlke K, Giles RT, Rafferty A, Cook ML, Khoury MJ. Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health. 2009 Mar; 99(3):442-5. PMID: 19106425; PMCID: PMC2661444.
    54. Goddard KA, Robitaille J, Dowling NF, Parrado AR, Fishman J, Bradley LA, Moore CA, Khoury MJ. Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics. 2009; 12(2):92-104. PMID: 19039253; PMCID: PMC2790792.
    55. Parimi N, Tromp G, Kuivaniemi H, Nien JK, Gomez R, Romero R, Goddard KA. Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia. BMC Med Genet. 2008 Jul 03; 9:60. PMID: 18598365; PMCID: PMC2474585.
    56. Hillian AD, Londono D, Dunn JM, Goddard KA, Pace RG, Knowles MR, Drumm ML. Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun. 2008 Sep; 9(6):501-8. PMID: 18563170; PMCID: PMC4255265.
    57. Blanton RE, Silva LK, Morato VG, Parrado AR, Dias JP, Melo PR, Reis EA, Goddard KA, Nunes MR, Rodrigues SG, Vasconcelos PF, Castro JM, Reis MG, Barreto ML, Teixeira MG. Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. Eur J Hum Genet. 2008 Jun; 16(6):762-5. PMID: 18270538.
      View in: PubMed
    58. Igo RP, Londono D, Miller K, Parrado AR, Quade SR, Sinha M, Kim S, Won S, Li J, Goddard KA. Density-based clustering in haplotype analysis for association mapping. BMC Proc. 2007; 1 Suppl 1:S27. PMID: 18466524; PMCID: PMC2367537.
    59. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Saad MF, Scavini M, Smith MW, Taylor K, Winkler CA, Zager PG, Shah VO. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes. 2008 Jan; 57(1):235-43. PMID: 18003762.
      View in: PubMed
    Goddard's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.